Sonographic and electrodiagnostic evaluations in patients with aromatase inhibitor-related arthralgia

Journal of Clinical Oncology

Volumn 27, Issue 30, 2009, Pages 4955-4960

  Dizdar, Omer ^a   Özçakar, Levent ^a   Malas, Fevziye Ünsal ^a   Harputluoglu, Hakan ^a   Bulut, Nilufer ^a   Aksoy, Sercan ^a   Ozisik, Yavuz ^a   Altundag, Kadri ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ANASTROZOLE; ANTINUCLEAR ANTIBODY; AROMATASE INHIBITOR; C REACTIVE PROTEIN; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; DOUBLE STRANDED DNA ANTIBODY; EXEMESTANE; LETROZOLE; RHEUMATOID FACTOR;

ADULT; ARTHRALGIA; ARTICLE; AUTOIMMUNITY; BREAST CANCER; CANCER STAGING; CARPAL TUNNEL SYNDROME; CLINICAL ASSESSMENT; CONTROLLED STUDY; ECHOGRAPHY; ELECTRODIAGNOSIS; ELECTROMYOGRAPHY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HAND JOINT; HORMONAL THERAPY; HUMAN; KNEE; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PREVALENCE; PRIORITY JOURNAL; SEROLOGY; TENDON; WRIST;

ADULT; AGED; AROMATASE INHIBITORS; ARTHRALGIA; BREAST NEOPLASMS; ELECTROMYOGRAPHY; FEMALE; HUMANS; MIDDLE AGED; POSTMENOPAUSE; PREVALENCE; PROSPECTIVE STUDIES; ULTRASONOGRAPHY;

EID: 77649128109     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2008.20.5435     Document Type: Article

References (29)

1. Howell A, Cuzick J, Baum M, et al: Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer. Lancet 365:60-62, 2005
2. Coombes RC, Hall E, Gibson LJ, et al: A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer. N Engl J Med 350:1081-1092, 2004
3. Thurlimann B, Keshaviah A, Coates AS, et al: A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer. N Engl J Med 353:2747-2757, 2005
4. Jakesz R, Jonat W, Gnant M, et al: Switching of postmenopausal women with endocrine-responsive early breast cancer to anastrozole after 2 years' adjuvant tamoxifen: Combined results of ABCSG trial 8 and ARNO 95 trial. Lancet 366:455-462, 2005
5. Conte P, Frassoldati A: Aromatase inhibitors in the adjuvant treatment of postmenopausal women with early breast cancer: Putting safety issues into perspective. Breast J 13:28-35, 2007
6. Coates AS, Keshaviah A, Thurlimann B, et al: Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer: Update of study BIG 1-98. J Clin Oncol 25:486-492, 2007
7. Brown WJ, Mishra GD, Dobson A: Changes in physical symptoms during the menopause transition. Int J Behav Med 9:53-67, 2002
8. Mishra GD, Brown WJ, Dobson AJ: Physical and mental health: Changes during menopause transition. Qual Life Res 12:405-412, 2003
9. Felson DT, Cummings SR: Aromatase inhibitors and the syndrome of arthralgias with estrogen deprivation. Arthritis Rheum 52:2594-2598, 2005
10. Goss PE, Ingle JN, Martino S, et al: A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer. N Engl J Med 349:1793-1802, 2003
11. Lønning PE, Geisler J, Krag LE, et al: Effects of exemestane administered for 2 years versus placebo on bone mineral density, bone biomarkers, and plasma lipids in patients with surgically resected early breast cancer. J Clin Oncol 23:5126-5137, 2005
12. Richette P, Corvol M, Bardin T: Estrogens, cartilage, and osteoarthritis. Joint Bone Spine 70:257-262, 2003
13. Toesca A, Pagnotta A, Zumbo A, et al: Estrogen and progesterone receptors in carpal tunnel syndrome. Cell Biol Int 32:75-79, 2008
14. Hofbauer LC, Kühne CA, Viereck V: The OPG/ RANKL/RANK system in metabolic bone diseases. J Musculoskel Neuron Interact 4:268-275, 2004
15. Oh SJ: Nerve conduction techniques, in Oh SJ (ed): Clinical Electromyography: Nerve Conduction Studies (ed 2). Baltimore, MD, Williams and Wilkins, 1993, pp 39-55
16. Buzdar A, Howell A, Cuzick J, et al: Comprehensive side-effect profile of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: Long-term safety analysis of the ATAC trial. Lancet Oncol 7:633-643, 2006
17. Sestak I, Cuzick J, Sapunar F, et al: Risk factors for joint symptoms in patients enrolled in the ATAC trial: A retrospective, exploratory analysis. Lancet Oncol 9:866-872, 2008
18. Crew KD, Greenlee H, Capodice J, et al: Prevalence of joint symptoms in postmenopausal women taking aromatase inhibitors for early-stage breast cancer. J Clin Oncol 25:3877-3883, 2007
19. Dent SF, Hopkins S, Di Valentin T, et al: Adjuvant aromatase inhibitors in early breast cancer-toxicity and adherence: Important observations in clinical practice. Breast Cancer Res Treat 106:S111, 2007 (suppl 1; abstr 2079)
20. Fontaine C, Vandenbossche K, Dewaele A, et al: Tolerance for adjuvant letrozole in daily practice. Breast Cancer Res Treat 94:S241, 2006 (suppl 1; abstr 5099)
21. Yamamoto Y, Kawasoe T, Ibusuki M, et al: Aromatase inhibitor-induced joint symptom in patients with breast cancer. J Clin Oncol 25:599s, 2007 (suppl; abstr 11070)
22. Morales L, Pans S, Verschueren K, et al: Prospective study to assess short-term intra-articular and tenosynovial changes in the aromatase inhibitor-associated arthralgia syndrome. J Clin Oncol 26:3147-3152, 2008
23. Aroori S, Spence RA: Carpal tunnel syndrome. Ulster Med J 77:6-17, 2008
24. Liu SH, al-Shaikh R, Panossian V, et al: Primary immunolocalization of estrogen and progesterone target cells in the human anterior cruciate ligament. J Orthop Res 14:526-533, 1996
25. Sciore P, Frank CB, Hart DA: Identification of sex hormone receptors in human and rabbit ligaments of the knee by reverse transcriptionpolymerase chain reaction: Evidence that receptors are present in tissue from both male and female subjects. J Orthop Res 16:604-610, 1998
26. Laroche M, Borg S, Lassoued S, et al: Joint pain with aromatase inhibitors: Abnormal frequency of Sjogren's syndrome. J Rheumatol 34:2259-2263, 2007
27. Azria D, Lamy P, Belkacemi Y, et al: Letrozole induced arthralgia is not consistent with an autoimmune disease resembling Sjögren's syndrome: Preliminary results of a multicentric prospective trial. Breast Cancer Res Treat 100:S25, 2007 (suppl 1; abstr 106)
28. Azria D, Lamy P, Belkacemi Y, et al: Letrozole-induced arthralgia: Results of a multicentric prospective trial exploring clinical parameters and plasma biomarkers. The 2007 ASCO Breast Cancer Symposium Proceedings, Chicago, IL, June 1-5, 2007 (abstr 228)
29. Singh S, Howell A, Cuzick J: Vit D levels among patients with Arthralgia: Results from IBIS-II breast cancer prevention study. Breast Cancer Res Treat 100:S61, 2007 (suppl 1; abstr 1068)